Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrodin injection for prevention of perioperative neurocognitive disorders after coronary artery bypass graft surgery
ChiCTR1800020414Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Dec 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gastrodin in perioperative neurocognitive disorder, postoperative delirium (POD) and post-operative cognitive decline (POCD) (2 arms), sponsored by Union Hospital. Primary endpoints: Cognitive function and Delirium. Started Dec 2018; status: recruiting.
02
Drugs
gastrodin
03
Conditions
perioperative neurocognitive disorderpostoperative delirium (POD)post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR1800020414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020414.